Perfusion Index and End Diastolic Velocity Ratios as Predictors of Supraclavicular Block Success in Vascular Access Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAssiut University

About this trial

This is a prospective observational study investigating the correlation between Perfusion Index (PI) ratio and End Diastolic Velocity (EDV) ratio as early predictors of successful supraclavicular brachial plexus block (SCBPB) in patients undergoing superficialization surgery of the upper limb.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18-65 years

Disqualifiers

Patient refusal

Trial population

Participants are adult patients aged 18-65 years, both male and female, classified as ASA II-VI, and scheduled for elective superficialization procedures (mainly AV fistula superficialization). Patients must be capable of understanding and signing informed consent. Excluded are patients with contraindications to nerve block such as coagulopathy, local infection, allergy to local anesthetics, severe vascular disease, morbid obesity (BMI \>35), severe neurological or psychiatric impairment, or those taking vasopressors or beta-blockers that could alter vascular reactivity.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

50 Participants
are grouped into 1 trial group
Group A: adult patients scheduled for elective superficialization surgery of the upper limb

Trial outcomes

Primary outcomes

1

Change in Perfusion Index ratio

Change in Perfusion Index ratio at 15 minutes after supraclavicular brachial plexus block in predicting successful block

Time frame
15 minutes
2

Change in End Diastolic Velocity ratio

Change in End Diastolic Velocity ratio at 15 minutes after supraclavicular brachial plexus block in predicting successful block

Time frame
15 minutes

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: